Nebulisation drugs
Pro Research Analysisby 
Searched over 200M research papers for "nebulisation drugs"
Nebulisation Drugs: An Overview of Delivery Systems and Efficacy
Introduction to Nebulisation Drug Delivery
Nebulisation is a widely used method for delivering medications directly to the lungs, particularly for treating respiratory conditions such as cystic fibrosis (CF) and severe acute asthma. This method allows high doses of drugs to be administered effectively despite airflow obstructions . Various nebuliser systems, including conventional, vibrating mesh technology (VMT), adaptive aerosol delivery (AAD), and ultrasonic nebulisers, are employed to optimize drug delivery Stanford2023Daniels2013.
Nebuliser Systems for Cystic Fibrosis
Conventional Nebulisers
Conventional nebulisers are commonly used in CF treatment. These systems vary in their efficiency based on flow rates, respirable fractions, and particle sizes. Higher flow rates and smaller particles generally result in decreased treatment times and increased drug deposition in the lungs, which are preferred by CF patients Stanford2023Daniels2013.
Advanced Nebuliser Technologies
Newer technologies such as AAD and VMT have shown significant advantages over conventional systems. These advanced systems reduce treatment times and improve drug deposition as a percentage of the priming dose. AAD systems, in particular, have demonstrated greater deposition efficiency compared to conventional systems Stanford2023Daniels2013. However, some VMT systems may experience increased system failures, highlighting the need for careful selection and maintenance .
Nebulised Medications for Acute Asthma
Magnesium Sulphate
Nebulised magnesium sulphate (MgSO₄) has been investigated for its potential benefits in severe acute asthma. However, studies have shown that neither nebulised nor intravenous MgSO₄ significantly reduces hospital admission rates or improves breathlessness compared to standard therapy . This suggests limited efficacy of MgSO₄ in acute asthma management.
Efficiency and Safety of Nebulised Antibiotics
Tobramycin
Tobramycin is a commonly nebulised antibiotic for CF patients. Studies comparing different nebuliser systems, such as the eFlow rapid and LC Plus jet nebulisers, indicate that while the eFlow rapid significantly reduces nebulisation time, it may result in lower lung deposition compared to the LC Plus nebuliser . This trade-off between treatment time and deposition efficiency must be considered when selecting a nebuliser system.
Gentamicin and Colistin
Efficient nebulisation of antibiotics like gentamicin and colistin is crucial for treating respiratory infections in CF patients. Research has shown that the choice of nebuliser and compressor significantly affects drug output, droplet size, and nebulisation time. For instance, the DeVilbiss and Turret nebulisers, when paired with a powerful compressor, provide efficient nebulisation of these antibiotics Newman1987Newman1985.
Nebulised Hypertonic Saline for Bronchiolitis
Nebulised hypertonic saline (≥3%) has been found to reduce hospital stay duration and improve clinical severity scores in infants with acute viral bronchiolitis. This treatment appears to be effective in both inpatient and outpatient settings, with no significant adverse events reported .
Conclusion
Nebulisation remains a critical method for delivering respiratory medications, with various systems offering different benefits and limitations. Advanced technologies like AAD and VMT provide improved treatment times and drug deposition, though they may come with higher failure rates. The choice of nebuliser system and medication must be tailored to individual patient needs, considering factors such as treatment efficiency, safety, and patient adherence. Further long-term studies are needed to evaluate the clinical outcomes and economic impact of these nebuliser systems.
Sources and full results
Most relevant research papers on this topic